BRAF V600 Mutation Detection FFPE Tissue test
New
6,635.00₹
In stock
All over India
0 Reviews
The BRAF V600 Mutation Detection FFPE Tissue test is a specialized molecular diagnostic assay designed to identify specific genetic mutations within the BRAF gene using formalin-fixed, paraffin-embedded tissue samples.
This test primarily targets the V600E and V600K amino acid substitutions, which result in constitutive activation of the MAPK/ERK signaling pathway and drive cellular proliferation in various cancers.
Oncologists utilize this diagnostic tool to evaluate patients with melanoma, colorectal cancer, and non-small cell lung cancer. Identifying a BRAF V600 mutation is critical for determining eligibility for targeted therapies, including specific BRAF and MEK inhibitors.
This test primarily targets the V600E and V600K amino acid substitutions, which result in constitutive activation of the MAPK/ERK signaling pathway and drive cellular proliferation in various cancers.
Oncologists utilize this diagnostic tool to evaluate patients with melanoma, colorectal cancer, and non-small cell lung cancer. Identifying a BRAF V600 mutation is critical for determining eligibility for targeted therapies, including specific BRAF and MEK inhibitors.
The BRAF V600 Mutation Detection FFPE Tissue test is a specialized molecular diagnostic assay designed to identify specific genetic mutations within the BRAF gene using formalin-fixed, paraffin-embedded tissue samples.
This test primarily targets the V600E and V600K amino acid substitutions, which result in constitutive activation of the MAPK/ERK signaling pathway and drive cellular proliferation in various cancers.
Oncologists utilize this diagnostic tool to evaluate patients with melanoma, colorectal cancer, and non-small cell lung cancer. Identifying a BRAF V600 mutation is critical for determining eligibility for targeted therapies, including specific BRAF and MEK inhibitors.
